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Abstract
The affinity state of nicotinic acetylcholine receptors (nAcChoRs) reconstituted into either dioleoylphosphatidylcholine
(DOPC) or a mixture of dioleoylphosphatidylcholine, dioleoylphosphatidic acid, and cholesterol (DOPC/DOPA/cholesterol)
has been determined using single and sequential mixing stopped-flow fluorescence spectroscopies. These techniques have
millisecond temporal resolution, permitting low- and high-affinity conformational states of the nAcChoR to be resolved
following mixing with the fluorescent partial agonist Dns-C6-Cho from their characteristic Dns-C6-Cho dissociation rates.
Our studies reveal that prior to agonist-induced affinity state conversion, nAcChoRs reconstituted into either DOPC or
DOPC/DOPA/cholesterol are predominantly in a conformational state that has a low affinity for agonist. Prolonged
exposure to Dns-C6-Cho converts nearly all DOPC/DOPA/cholesterol-reconstituted nAcChoRs to the high-affinity state. In
contrast, Dns-C6-Cho converts only half of all DOPC-reconstituted nAcChoRs to the high-affinity state. The other half
persists in a low-affinity state characterized by a Kd for Dns-C6-Cho of 0.61 þ 0.07 WM. This Kd is similar to that previously
reported for Dns-C6-Cho binding to low-affinity, resting-state nAcChoRs in native membranes. However, affinity state
conversion of DOPC-reconstituted nAcChoRs may be facilitated by re-reconstituting them into bilayers composed of
DOPC/DOPA/cholesterol. These results indicate that the lipid bilayer composition modulates nAcChoR agonist-induced
affinity state transitions. 0005-2736 / 98 / $ ^ see front matter ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
The nicotinic acetylcholine receptor (nAcChoR) is
the prototypical member of a superfamily of struc-
turally and functionally similar intrinsic membrane
proteins that also includes the GABAA, glycine,
and 5-HT3 receptors [1^3]. Detailed biophysical and
biochemical studies have shown that in the absence
of agonist, native nAcChoRs exist in an equilibrium
between two conformational states: a resting state
that is characterized by a low a⁄nity for agonist
and a desensitized one that has a high a⁄nity for
agonist [4,5]. In the absence of agonist, most nAc-
ChoRs in native membranes are in the low-a⁄nity
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Abbreviations: nAcChoR, nicotinic acetylcholine receptor;
DOPA, dioleoylphosphatidic acid; DOPC, dioleoylphosphatidyl-
choline; Dns-C6-Cho, [1-[5-(dimethylamino) naphthalene]sulfo-
namido]-n-hexanoic acid L-(N-trimethylammonium bromide) eth-
yl ester; TPS, Torpedo physiological saline
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resting state. The binding of two agonist molecules
to receptors in the resting state leads to a conforma-
tional isomerization ¢rst to an open channel state
and ultimately to a set of closed desensitized states
[6^8]. Agonists may also bind to receptors in the
desensitized state, but this does not lead to channel
opening.
Previous studies using reconstituted nAcChoRs
have demonstrated that speci¢c lipids are needed to
maintain normal receptor function [9^12]. In partic-
ular, cholesterol or cholesterol analogs and nega-
tively charged lipids appear to be necessary to
preserve agonist-induced channel opening in recon-
stituted nAcChoRs [13^15]. However, the role that
lipids play in preserving the ability of reconstituted
nAcChoRs to bind agonist and undergo agonist-in-
duced transitions to higher a⁄nity states remains
unresolved. Toxin binding assays suggest that even
in the absence of agonist, receptors reconstituted into
bilayers devoid of cholesterol (or cholesterol analogs)
and negatively charged phospholipids are predomi-
nantly in the desensitized state and, therefore, fail
to undergo an a⁄nity state transition upon agonist
exposure [14,16]. This conclusion was supported by
the results of photolabeling experiments showing that
even in the absence of agonist, nAcChoRs reconsti-
tuted into phosphatidylcholine are labeled by the
photoactivatable probe [125I]TID in a pattern that
is indicative of receptors in the desensitized state
[16]. However, Criado et al. concluded from their
own studies of toxin binding kinetics that nAcChoRs
reconstituted into phosphatidylcholine are stabilized
in a receptor state that has a low a⁄nity for agonist
[17]. Finally, in contrast to all of the above men-
tioned studies, Dalziel et al. [18] and Ochoa et al.
[13] have reported that nAcChoRs reconstituted
into DOPC retain their ligand binding properties
and their ability to undergo agonist-induced a⁄nity
state transitions.
We have recently developed a new approach for
detecting and characterizing agonist binding and af-
¢nity state transitions in nAcChoR-rich membranes
using stopped-£ow £uorescence spectroscopy [19].
This approach resolves agonist binding to high-
and low-a⁄nity receptor states from the dissociation
rate of the £uorescent partial agonist, Dns-C6-Cho,
following chemical dilution into acetylcholine. Be-
cause the binding of Dns-C6-Cho to nAcChoRs
can be resolved within milliseconds of mixing, Dns-
C6-Cho-induced desensitization may be detected as a
time-dependent increase in the number of high-a⁄n-
ity binding sites upon exposure to the agonist. The
present work uses this approach to de¢ne the con-
formational state of nAcChoRs reconstituted into
DOPC and to determine whether such receptors
undergo a change in a⁄nity state upon equilibration
with agonist. We have focused on nAcChoRs that
have been reconstituted into pure phosphatidylcho-
line (DOPC) because previous studies have failed to
arrive at a consensus regarding the a⁄nity state of
such receptors or their ability to undergo agonist-
induced a⁄nity state transitions. For comparison,
we also assessed the a⁄nity state of nAcChoRs re-
constituted into DOPC/DOPA/cholesterol (molar ra-
tio 63:12:25), a lipid mixture that simulates the ster-
oid and charge density of native membranes.
2. Materials and methods
2.1. Membrane preparation, reconstitution, and
characterization
Electric organs were obtained from Torpedo nobili-
ana (Bio¢sh Associates Georgetown, MA) as previ-
ously described and approved by the Massachusetts
General Hospital Animal Care and Use Committee
[20]. The nAcChoR was reconstituted using a mod-
i¢cation of the procedure of Ellena et al. in which
A⁄-Gel 201 was derivatized with DL-N-acetylhomo-
cysteine thiolactone and used in place of A⁄-Gel 401
[21]. The a⁄nity column was washed with either
DOPC alone or a mixture of DOPC, DOPA, and
cholesterol to obtain the desired membrane lipid
composition. The protein content of reconstituted
nAcChoR membranes was determined as described
by Markwell et al. using bovine serum albumin as
the standard [22], and the number of agonist binding
sites was estimated by assuming a molecular mass of
290 000 and two binding sites/receptor. The choles-
terol and phospholipid content of reconstituted
membranes were determined by previously reported
methods [23,24]. Lipid/protein ratios typically ranged
from 200 to 400. In some cases, receptors reconsti-
tuted into DOPC were re-reconstituted into DOPC/
DOPA/cholesterol using the method of Ochoa et al.
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[13]. For experiments using native membranes, ace-
tylcholinesterase activity was inhibited with diisopro-
pyl£uorophosphate. The number of agonist binding
sites in native membrane preparations was deter-
mined as previously described [19]. Dns-C6-Cho
was synthesized according to the procedure of Waks-
man et al. [25].
2.2. Stopped-£ow £uorescence spectroscopy
Single and sequential mixing stopped-£ow £uores-
cence spectroscopies were performed with an Applied
Photophysics SX.17MV stopped-slow spectro-
£uorimeter (Leatherhead, UK). An excitation wave-
length of 290 nm was provided by a 150-W xenon
arc lamp. The bandpass on the monochrometer was
2.5 nm. Fluorescence was detected through a 530-nm
high-pass ¢lter on a logarithmic timebase typically
for either 10 or 100 s. The temperature was kept at
10.0 þ 0.2‡C with a circulator bath. In a typical ex-
periment, 5 to 10 individual shots were signal aver-
aged to reduce noise. Signal averaged £uorescence
traces were transferred to a Macintosh computer
and analyzed using the commercially available anal-
ysis program Igor 3.0 (Wavemetrics, Lake Oswego,
OR).
2.3. Single mixing stopped-£ow £uorescence
spectroscopy
Reconstituted nAcChoRs were ¢rst preequili-
brated with the £uorescent partial agonist Dns-C6-
Cho for 1^2 h and then loaded into one of the spec-
tro£uorimeter’s premix syringes. Acetylcholine (2 mM
in TPS) and Dns-C6-Cho were loaded into the other
to maintain a nearly constant aqueous concentration
of the £uorescent partial agonist upon mixing. The
two solutions were rapidly mixed (1:1, v/v) into an
optical cell where the £uorescence intensity was re-
corded.
2.4. Sequential mixing sopped-£ow £uorescence
spectroscopy
Sequential mixing stopped-£ow £uorescence spec-
troscopy was performed as previously described [19].
In brief, reconstituted receptor membranes were
loaded into one of the spectro£uorimeter’s premix
syringes and a solution of Dns-C6-Cho was loaded
into the other. Receptor membranes and Dns-C6-
Cho were then mixed (1:1 v/v). After the desired
preincubation period, the receptor/Dns-C6-Cho solu-
tion was mixed (1:1 v/v) with a solution containing
2 mM acetylcholine plus Dns-C6-Cho at half the
concentration present in the premix syringe to main-
tain a nearly constant free Dns-C6-Cho concentra-
tion with the second mixing step. This second mixing
step occurred within the optical cell where changes in
£uorescence emission were recorded. The time axis
on all stopped-£ow £uorescence traces refers to the
time after the second mixing step. The reported nAc-
ChoR and Dns-C6-Cho concentrations are those
during the preincubation period.
2.5. Interpretation of stopped-£ow £uorescence traces
[26]
Under conditions of energy transfer from receptor
tryptophan to the dansyl moiety of Dns-C6-Cho, the
binding of Dns-C6-Cho to the nAcChoR produces
an increase in £uorescence emission above 530 nm
[4,26,27]. Subsequent chemical dilution into the non-
£uorescent agonist acetylcholine reduces this £uores-
cence as acetylcholine exchanges with Dns-C6-Cho
for agonist binding sites on the receptor [4]. Because
the di¡erent agonist binding a⁄nities exhibited by
nAcChoR conformational states largely re£ect their
di¡erent agonist dissociation rates [28,29], Dns-C6-
Cho binding to high- and low-a⁄nity receptors
may be distinguished from the time scale of the £uo-
rescence decay upon dilution into a non£uorescent
agonist; Dns-C6-Cho dissociates slowly from high-
a⁄nity receptors but rapidly from low-a⁄nity ones.
Sequential mixing stopped-£ow £uorescence spectro-
scopy allows membranes to be preequilibrated with
Dns-C6-Cho for periods of time ranging from milli-
seconds to minutes before dilution into acetylcholine.
With very short preincubation times, two £uorescent
decays are observed in native nAcChoR membranes.
There is a fast decay on the time scale of millise-
conds, re£ecting Dns-C6-Cho dissociation from one
of the two agonist binding sites on resting-state nAc-
ChoRs. This site has a Kd of 1.1 WM. Although Dns-
C6-Cho also binds to the other resting-state site, it
does so with a much lower a⁄nity and dissociates
from this site within the 1 ms mixing time of the
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spectro£uorimeter. Therefore, this site is not de-
tected. There is also a slow decay on the time scale
of seconds, re£ecting Dns-C6-Cho dissociation from
the two high-a⁄nity sites on desensitized nAcChoRs
(KdV3 nM). With longer preincubation times that
permit low-a⁄nity nAcChoRs to undergo signi¢cant
Dns-C6-Cho-induced a⁄nity state conversion to the
high-a⁄nity state prior to mixing with acetylcholine,
the amplitude of the slow decay increases while that
of the fast decay decreases. With very long preincu-
bation times, no fast decay is detectable in native
membranes because essentially all receptors have
been converted to the high-a⁄nity state prior to mix-
ing with acetylcholine.
3. Results
3.1. Single mixing stopped-£ow £uorescence
spectroscopic studies of nAcChoRs
reconstituted into DOPC
Fig. 1A shows typical £uorescence decays obtained
when nAcChoR-rich native membranes or nAc-
ChoRs reconstituted into DOPC (0.7 WM agonist
binding sites) were equilibrated for 1^2 h with 8
WM Dns-C6-Cho and then rapidly mixed with 1
mM acetylcholine. To facilitate comparison between
these two preparations, the initial £uorescence inten-
sity of each trace has been normalized to 1.0. Native
and DOPC-reconstituted membranes each exhibited
a slow £uorescence decay on the slow time scale pre-
viously reported for Dns-C6-Cho dissociation from
high-a⁄nity, desensitized nAcChoRs [4,19]. We
noted that these slow decays deviated from a simple
¢rst-order process, but could be well ¢t to a double
exponential equation. Fig. 1B shows the same traces
as in Fig. 1A except that the ¢rst second has been
expanded to reveal an additional (intermediate) £uo-
rescence decay in the trace obtained with nAcChoRs
reconstituted into DOPC. This intermediate compo-
nent occurred on the time scale of tens of millise-
conds and was not observed in traces obtained using
native membranes. The amplitude and rate of this
additional decay, determined by ¢tting the £uores-
cence trace to a triple exponential equation, were
0.379 þ 0.003 and 48 þ 1 s31. The rapid rate of the
intermediate decay is indicative of Dns-C6-Cho dis-
sociation from a class of sites that has a low a⁄nity
for agonist. Preequilibrating membranes with the
competitive antagonist K-bungarotoxin prior to per-
forming these stopped-£ow studies eliminated the in-
termediate and slow decays (data not shown).
Fig. 2A shows the slow £uorescent decays ob-
Fig. 1. Single mixing stopped-£ow £uorescence traces of native and DOPC-reconstituted nAcChoRs. Panel A shows the change in £u-
orescence intensity recorded when nAcChoRs reconstituted into DOPC or nAcChoR-rich native membranes (0.7 WM agonist binding
sites) are ¢rst preequilibrated with Dns-C6-Cho for 1^2 h and then rapidly mixed with 1 mM acetylcholine. On this time scale a slow
£uorescent decay is observed re£ecting competitive displacement of the £uorescent agonist Dns-C6-Cho by acetylcholine from high-af-
¢nity agonist binding sites on nAcChoRs. Panel B shows the same traces as panel A with the ¢rst second expanded to reveal an addi-
tional (intermediate) decay in the trace recorded using nAcChoRs reconstituted into DOPC. No signi¢cant intermediate decay is ob-
served in nAcChoR-rich native membranes. The dotted lines are derived by ¢tting the £uorescence traces to either a double
exponential (native) or triple exponential (DOPC-reconstituted) equation.
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served when receptors reconstituted into DOPC (¢-
nal concentration 0.13 WM agonist sites) were pre-
equilibrated with either 0.25 WM or 8 WM Dns-C6-
Cho and then rapidly mixed with 1 mM acetylcho-
line. This low concentration of receptor was used to
minimize depletion of Dns-C6-Cho from the aqueous
phase. On the slow time scale shown in this ¢gure,
the two traces nearly overlap. Fig. 2A is expanded in
Fig. 2B to show that the amplitude of the intermedi-
ate decay is signi¢cantly larger in the trace obtained
using the higher concentration of Dns-C6-Cho. Be-
cause the amplitude of the intermediate and slow
decay re£ect the number of low- and high-a⁄nity
sites, respectively, that had bound Dns-C6-Cho dur-
ing equilibration, we evaluated the a⁄nity of Dns-
C6-Cho for these sites by measuring the amplitudes
these decays as a function of Dns-C6-Cho concentra-
tion (Fig. 3). There was little increase in the ampli-
tude of the slow decay with increasing Dns-C6-Cho
concentration, indicating that these sites were nearly
saturated even at concentrations of Dns-C6-Cho as
low as 0.25 WM. In contrast, the amplitude of the
intermediate decay increased signi¢cantly with Dns-
C6-Cho before reaching a plateau by approximately
4 WM, consistent with the titration of low-a⁄nity
Dns-C6-Cho binding sites. The concentration of
Dns-C6-Cho producing a half-maximal intermediate
decay amplitude was determined by ¢tting the ampli-
tude data to the logistic equation:
Amp  AmpmaxU Dns3C63Cho
n
Dns3C63Chon  Knd
 
1
where Amp is the amplitude of the intermediate de-
cay, Ampmax is the maximal amplitude reached at
high Dns-C6-Cho concentrations, n is the Hill coef-
¢cient, and Kd is the Dns-C6-Cho concentration pro-
ducing a half-maximal amplitude. The value of Kd
was determined to be 0.61 þ 0.07 WM and the Hill
coe⁄cient was 1.1 þ 0.2. In three separate prepara-
tions, the amplitudes of the intermediate and slow
Fig. 2. Single mixing stopped-£ow £uorescence traces of
DOPC-reconstituted nAcChoRs. Panel A shows the change in
£uorescence intensity recorded when nAcChoRs reconstituted
into DOPC (0.13 WM agonist binding sites) that have been pre-
equilibrated with either 0.25 or 8 WM Dns-C6-Cho for 1^2 h
are rapidly mixed with 1 mM acetylcholine. Panel B shows the
¢rst second of panel A. The dotted lines are ¢ts of £uorescence
traces to a triple exponential equation.
Fig. 3. Plot of the amplitudes of the intermediate (b) and slow
(a) decays following preequilibration with Dns-C6-Cho at the
indicated concentrations. In each Dns-C6-Cho titration, the
component amplitudes were normalized to the total £uorescence
change observed using 30 WM Dns-C6-Cho, the highest concen-
tration studied. The line is a ¢t of the data to Eq. 1 yielding a
Kd of 0.61 þ 0.07 WM, a Hill coe⁄cient was 1.1 þ 0.2, and an
Ampmax of 0.49 þ 0.02.
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decays represented 46 þ 9% and 54 þ 9%, respectively,
of the total reduction in £uorescence observed when
receptors that have been preincubated with saturat-
ing concentrations of Dns-C6-Cho (s 8 WM) are di-
luted into 1 mM acetylcholine.
3.2. Sequential mixing stopped-£ow £uorescence
spectroscopic studies of nAcChoRs reconstituted
into DOPC
Fig. 4A shows typical £uorescence traces obtained
when nAcChoRs reconstituted into DOPC (0.4 WM)
were preincubated with 10 WM Dns-C6-Cho for times
ranging from 50 ms to 100 s and then rapidly mixed
with acetylcholine. With Dns-C6-Cho^nAcChoR pre-
incubation times su⁄ciently short to minimize Dns-
C6-Cho-induced a⁄nity state conversion of nAc-
ChoRs (i.e. 50 ms), the amplitude of the slow decay
was 0.06. This indicated that few of the nAcChoRs
were in the high-a⁄nity state at the time of dilution
into acetylcholine. However, with longer preincuba-
tion times, the amplitude of the slow decay increased
re£ecting an increase in the number of the high-af-
¢nity nAcChoRs. The apparent rate with which Dns-
C6-Cho induced this a⁄nity state conversion, deter-
mined by ¢tting the slow decay amplitude data in
Fig. 4A to an exponential equation, yielded a value
of 0.6 þ 0.1 s31 (inset). Fig. 4B reveals the ¢rst se-
cond of the traces in Fig. 4A. With long preincuba-
tion times (i.e. 100 s), the intermediate decay was
similar to that observed in single mixing studies using
receptors that had been preequilibrated with Dns-C6-
Cho prior to diluting into acetylcholine (compare
with Fig. 1B). However, with short preincubation
times (i.e. 50 ms), an exponential decay was observed
that was signi¢cantly faster than the intermediate
decay observed in the single mixing studies (Fig.
4B). This suggested that when nAcChoRs were ex-
posed only brie£y to Dns-C6-Cho, they bound the
£uorescent agonist with an a⁄nity that was even
lower than that observed at equilibrium. In 24 ex-
periments using Dns-C6-Cho concentrations ranging
from 0.5 to 20 WM, the fast decay rate averaged
160 þ 60 s31. This in the range previously reported
for Dns-C6-Cho dissociation from one of the agonist
binding sites on the nAcChoR resting state. The af-
¢nity of this site for Dns-C6-Cho was determined
from a plot of the amplitude of the fast decay as a
function of Dns-C6-Cho (Fig. 5). This amplitude in-
creased with Dns-C6-Cho concentration and then
plateaued. The concentration of Dns-C6-Cho pro-
ducing a half-maximal increase in the amplitude of
the fast decay was 1.4 þ 0.2 WM and the Hill coe⁄-
cient was 1.1 þ 0.2.
Fig. 4. Sequential mixing stopped-£ow £uorescence traces of
DOPC-reconstituted nAcChoRs. Panel A shows the change in
£uorescence intensity recorded when nAcChoRs reconstituted
into DOPC are preincubated with 10 WM Dns-C6-Cho for the
indicated times (in seconds) and then chemically diluted into
1 mM acetylcholine. The dotted lines are ¢ts of £uorescence
traces to a triple exponential equation. The inset is a plot of
the amplitude of the slow decay as a function of preincubation
time. The slow decay amplitude was taken as the sum of the
amplitudes of the two slower components in a triple exponen-
tial ¢t of the trace. The line is a ¢t of the amplitude data to an
exponential equation yielding an apparent rate of 0.6 þ 0.1 s31.
Panel B shows the ¢rst second of panel A to reveal, depending
on the preincubation time, the fast or intermediate decays. A
small £uorescence enhancement on the time scale of several
hundred ms is also noted in the 0.05-s preincubation trace
which re£ects Dns-C6-Cho interactions with the agonist-inhibi-
tory site [19].
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3.3. Stopped-£ow £uorescence spectroscopic studies of
nAcChoRs reconstituted into
DOPC/DOPA/cholesterol
To determine whether reconstituting nAcChoRs
into a more native-like lipid membrane enhanced
the ability of receptors to undergo an a⁄nity state
transition upon agonist exposure, we examined the
kinetics of Dns-C6-Cho dissociation from nAcChoRs
reconstituted into a mixture of DOPC, DOPA, and
cholesterol (molar ratio 63:12:25). In previous stud-
ies, this lipid mixture has been shown to support
nAcChoR channel activation. Fig. 6A shows typical
£uorescence traces obtained when nAcChoRs recon-
stituted into DOPC/DOPA/cholesterol are preincu-
bated with 10 WM Dns-C6-Cho for various times
and then chemically diluted into 1 mM acetylcholine.
As observed in £uorescence traces obtained using
nAcChoRs reconstituted into DOPC, the slow decay
is relatively small with short preincubation times.
However, with longer preincubation times, the am-
plitude of the slow decay increased to 0.87 with an
apparent rate of 0.7 þ 0.2 s31 (see inset) With long
preincubation times, the amplitude of the fast decay
was 13 þ 2% of the total reduction in £uorescence
upon diluting into acetylcholine (n = 3 preparations),
a value that is signi¢cantly less than the 46 þ 9%
observed when nAcChoRs are reconstituted into
DOPC alone (Fig. 6B). Similarly, re-reconstituting
DOPC-reconstituted nAcChoRs into DOPC/DOPA/
cholesterol reduced the amplitude of the intermediate
decay to 24 þ 2% (n = 3 preparations).
Fig. 6. Sequential mixing stopped-£ow £uorescence traces of
DOPC/DOPC/cholesterol-reconstituted nAcChoRs. Panel A
shows the change in £uorescence intensity recorded when nAc-
ChoRs reconstituted into DOPC/DOPC/cholesterol are preincu-
bated with 10 WM Dns-C6-Cho for the indicated times and then
chemically diluted into 1 mM acetylcholine. The dotted lines
are ¢ts of £uorescence traces to a triple exponential equation.
The inset is a plot of the amplitude of the slow decay as a
function of preincubation time. The line is a ¢t of the ampli-
tude data to an exponential equation yielding an apparent rate
of 0.7 þ 0.2 s31. Panel B shows the ¢rst second of panel A to
reveal, depending on the preincubation time, the fast or inter-
mediate decays. A small £uorescence enhancement on the time
scale of several hundred ms is also noted in the 0.05-s preincu-
bation trace which re£ects Dns-C6-Cho interactions with the ag-
onist-inhibitory site [19].
Fig. 5. Dns-C6-Cho concentration dependence of the fast decay
amplitude using a 50-ms preincubation time. The amplitudes
have been normalized to that obtained using 15 WM Dns-C6-
Cho. The concentration of DOPC-reconstituted nAcChoRs was
0.13 WM. The data points are an average ( þ S.D.) of three sep-
arate determinations using the same preparation. The data is ¢t
to Eq. 1 yielding a Kd of 1.4 þ 0.2 WM and a Hill coe⁄cient of
1.1 þ 0.2.
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4. Discussion
In single mixing studies, native and DOPC-recon-
stituted nAcChoRs were preequilibrated with the £u-
orescent partial agonist Dns-C6-Cho and then rap-
idly mixed with acetylcholine. In experiments using
either membrane preparation, a slow £uorescence de-
cay was observed re£ecting Dns-C6-Cho dissociation
from high-a⁄nity binding sites on desensitized nAc-
ChoRs [4,19]. However, in experiments using DOPC-
reconstituted nAcChoRs, an additional £uorescence
decay was observed. This decay was essentially com-
plete by 200 ms and could be eliminated by preincu-
bating membranes with K-bungarotoxin. This is in-
dicative of Dns-C6-Cho interactions with low-a⁄nity
agonist binding sites on DOPC-reconstituted nAc-
ChoRs. An estimate of the Kd of these sites was
made by titrating them with Dns-C6-Cho and then
using the amplitude of the intermediate decay as a
measure of the fraction of sites that had bound Dns-
C6-Cho prior to its being displaced by acetylcholine.
This experiment is shown in Fig. 3 and yielded a Kd
of 0.61 þ 0.07 WM.
It is possible to estimate the fraction of all low-
a⁄nity sites that have bound Dns-C6-Cho from the
fractional amplitude of the fast decay provided that
the relative £uorescence intensity of Dns-C6-Cho
bound to low- and high-a⁄nity states is known.
We have previously computer-modeled the £uores-
cence intensity (amplitude) of Dns-C6-Cho bound
to low- and high-a⁄nity sites in native membranes
and determined that Dns-C6-Cho £uorescence varies
little with the a⁄nity of the site to which it is bound
[19]. Thus, the fractional amplitudes of the inter-
mediate and slow decays may be taken directly as
approximate measures of the fractions of Dns-C6-
Cho-bound sites having low and high a⁄nity, respec-
tively. The absence of an intermediate decay in traces
obtained with nAcChoR-rich native membranes
equilibrated with saturating concentrations of Dns-
C6-Cho indicates that Dns-C6-Cho converts essen-
tially all preexisting low-a⁄nity receptors to a state
that has a high a⁄nity for agonist. Similarly, nearly
all DOPC/DOPA/cholesterol-reconstituted nAc-
ChoRs are converted by Dns-C6-Cho to a high-a⁄n-
ity state as indicated by the small fractional ampli-
tude of the intermediate decay in these membranes
(13 þ 2%). In contrast, the relatively large fractional
amplitude of the intermediate decay observed when
nAcChoRs are reconstituted into DOPC alone
(47 þ 9%) implies that many nAcChoRs persist in a
low-a⁄nity state even after exposing them to excess
Dns-C6-Cho for 1^2 h. The amplitude of this inter-
mediate decay may be reduced by re-reconstituting
them from DOPC into DOPC/DOPA/cholesterol,
suggesting that a signi¢cant fraction of nAcChoRs
can recover their ability to undergo a⁄nity state con-
version to the high-a⁄nity state if they are returned
to a lipid environment that more closely resembles
that found in nAcChoR-rich native membranes.
To de¢ne the a⁄nity state of reconstituted nAc-
ChoRs prior to agonist-induced a⁄nity state transi-
tions, we used Dns-C6-Cho preincubation times as
brief as 50 ms before dilution into acetylcholine.
With a preincubation time this short, agonist a⁄nity
state conversion during Dns-C6-Cho preincubation is
minimized. In all experiments, a Dns-C6-Cho con-
centration of 10 WM was used to saturate the low-
and high-a⁄nity sites detected with single mixing ex-
periments. We also expect that at this Dns-C6-Cho
concentration, the process of Dns-C6-Cho binding to
preexisting receptor conformational states will be in
pseudoequilibrium even when using preincubation
times as short as 50 ms [19]; assuming an association
rate constant as slow as 107 M31 s31, the t1=2 for
binding is less than 7 ms. This allowed us to monitor
the conformational transitions that follow Dns-C6-
Cho binding. Fig. 4A and Fig. 6A show that with
a 50-ms preincubation time, the amplitude of slow
decay was relatively small, indicating that few nAc-
ChoRs were in the high-a⁄nity state at the time of
dilution into acetylcholine. However, the amplitude
increased with longer preincubation times as Dns-C6-
Cho shifted approximately half (DOPC) or nearly all
(DOPC/DOPA/cholesterol) agonist binding sites on
reconstituted nAcChoRs to the high-a⁄nity state.
In addition to the low-a⁄nity sites detected fol-
lowing equilibration of reconstituted receptors with
Dns-C6-Cho, we also detected K-bungarotoxin dis-
placeable, low-a⁄nity sites by using a preincubation
times of 50 ms. These low-a⁄nity sites appear to be
conformationally distinct from those observed fol-
lowing equilibration with Dns-C6-Cho because they
are characterized by a faster dissociation rate con-
stant and a higher Kd for the £uorescent agonist.
However, the kinetic constants de¢ning this low-af-
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¢nity site are essentially identical to those of the
transient low-a⁄nity resting-state sites detected
under identical conditions in nAcChoR-rich native
membranes [19]. It seems reasonable to assume,
therefore, that the low-a⁄nity site detected in recon-
stituted nAcChoR membranes following a 50-ms pre-
incubation time also re£ects Dns-C6-Cho interactions
with the resting state.
In previous studies, the ability of reconstituted
nAcChoRs to undergo the transition from low- to
high-a⁄nity has been most commonly evaluated in-
directly with a K-bungarotoxin competition assay
[9,11,13,14,16]. This assay compares the rates of K-
bungarotoxin binding when (1) added to membranes
simultaneously with agonist or (2) added to mem-
branes that have been preequilibrated with agonist.
The nAcChoR is typically judged to be in the low-
a⁄nity state and capable of undergoing an a⁄nity
state transition with agonist exposure if the simulta-
neous addition of K-bungarotoxin and agonist results
in an initial rate of K-bungarotoxin binding that is
greater than that determined following preequilibra-
tion with agonist [14,16]. Conversely, if these binding
rates are not di¡erent, then the nAcChoR is assumed
to preexist in the high-a⁄nity state. Unfortunately,
the initial rates of K-bungarotoxin binding under
these two experimental conditions typically di¡er
by less than a factor of 2 even when using nAcChoRs
that have been reconstituted into lipids that are be-
lieved to maintain the receptor’s ability to undergo
agonist-induced a⁄nity state transitions [14]. The
small di¡erence may make data interpretation di⁄-
cult even under the best of circumstances. Because
preequilibrating DOPC-reconstituted nAcChoRs
with agonist leaves a signi¢cant fraction of the nAc-
ChoRs in a relatively low-a⁄nity state, the di¡erence
in the K-bungarotoxin binding rates measured in this
assay is predicted to be even smaller; the rate of K-
bungarotoxin binding to nAcChoRs preincubated
with agonist will be relatively high because of the
persistence of nAcChoRs that bind agonist with
low a⁄nity. Furthermore, the K-bungarotoxin com-
petition assay assumes that the apparent rate of de-
sensitization induced by agonist upon simultaneous
addition is slow on the time scale of K-bungarotoxin
binding. Our studies show that even at a concentra-
tion of 10 WM, Dns-C6-Cho signi¢cantly alters the
preexisting equilibrium in less than 1 s.
A smaller number of studies have suggested that
nAcChoRs reconstituted into DOPC are fully capa-
ble of undergoing a transition from the low-a⁄nity
to the high-a⁄nity state [13,18]. However, these stud-
ies used a lipid dilution technique that does not re-
move endogenous lipids. These endogenous lipids
may support function even when present in the mem-
brane at relatively low mole fractions. For example,
adding just 6 mol% cholesterol to DOPC-reconsti-
tuted nAcChoRs will signi¢cantly promote channel
activation [30]. Furthermore, because a substantial
pool of cholesterol is strongly associated with the
nAcChoR, dilution may leave a signi¢cant amount
of cholesterol at the receptor’s annular and nonan-
nular cholesterol binding sites [31]. In contrast, our
studies used a⁄nity column puri¢cation, a process
that removes endogenous lipid.
McCarthy and Moore have used a structural assay
to de¢ne the conformational state of reconstituted
nAcChoRs [16,32]. They characterized the labeling
of native and reconstituted nAcChoRs by the photo-
reactive, hydrophobic probe [125I]TID in the absence
of agonist and following agonist preequilibration,
then used the labeling pattern as an indicator of
the nAcChoR’s conformational state. They found
that receptors reconstituted into DOPC exhibited a
pattern of labeling that closely resembled that ob-
served in agonist desensitized native membranes.
This data was interpreted as evidence that nAc-
ChoRs reconstituted into DOPC were in the desen-
sitized state. These results are not necessarily in con-
£ict with ours. White and Cohen have shown that
agonist-modulated [125I]TID incorporation re£ects
interactions with the M2 transmembrane domain, a
site that is quite distinct from the extramembraneous
agonist binding domain characterized in the present
study [33,34]. Therefore, it is conceivable that the
di¡erence between our results and those of White
and Cohen re£ects the probing of di¡erent regions
of the receptor.
In a recent study, Rankin et al. used the £uores-
cent channel blocker ethidium to detect nAcChoR
channel activation and concluded that nAcChoRs
reconstituted into DOPC alone fail to open in re-
sponse to agonist [30]. Similarly, radiotracer studies
have shown that agonists do not induce ion £ux
through nAcChoRs reconstituted into DOPC
[35,36]. Our studies prove that the inability of
BBAMEM 77451 9-9-98
D.E. Raines, N.S. Krishnan / Biochimica et Biophysica Acta 1374 (1998) 83^93 91
DOPC-reconstituted nAcChoRs to open and allow
ion £ux does not result from their being locked in
the high-a⁄nity, desensitized state as previously sug-
gested. Rather, such receptors largely preexist in a
conformational state that exhibits a low a⁄nity for
agonist, and a substantial fraction remain that way
even following prolonged agonist exposure. However
unlike the resting-state conformation, these low-a⁄n-
ity receptors remain in a closed state even upon ex-
posure to high concentrations of agonist.
In summary, we have characterized the a⁄nity
state of nAcChoRs reconstituted into bilayers com-
posed of DOPC alone or a mixture of DOPC,
DOPA, and cholesterol prior to and following ago-
nist-induced a⁄nity state transitions. In contrast to
several previous studies using K-bungarotoxin bind-
ing as a measure of nAcChoR a⁄nity state, our re-
sults indicate that prior to agonist-induced a⁄nity
state conversion, nAcChoRs reconstituted into either
DOPC or DOPC/DOPA/cholesterol are predomi-
nantly in a conformational state that has a low af-
¢nity for agonist. Equilibration with the £uorescent
agonist Dns-C6-Cho converts nearly all DOPC/
DOPA/cholesterol-reconstituted nAcChoRs to the
high-a⁄nity state. However, equilibration with
Dns-C6-Cho converts only half of all DOPC-recon-
stituted nAcChoRs to the high-a⁄nity state. The
other half persist in a low-a⁄nity inactivatable con-
formational state, characterized by a Kd for Dns-C6-
Cho that is similar, but not identical, to that previ-
ously reported for its binding to low-a⁄nity, resting-
state nAcChoRs in native membranes.
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